Mitsubishi Tanabe Pharma America
Mitsubishi Tanabe Pharma America is dedicated to helping people with serious and debilitating diseases through innovative scientific solutions. With a legacy of over 300 years in medical advances, the company focuses on unmet medical needs in areas such as autoimmune disorders, diabetes, kidney diseases, and central nervous system diseases. They uphold values of integrity, collaboration, respect, persistence, and bravery, aiming to make a meaningful difference in patients' lives.
Industries
Nr. of Employees
medium (51-250)
Mitsubishi Tanabe Pharma America
Jersey City, New Jersey, United States, North America
Products
Oral free-radical scavenger therapy for ALS (approved formulation)
An approved small-molecule antioxidant formulation indicated for treatment of amyotrophic lateral sclerosis; available in an oral formulation with associated post-approval safety monitoring and real-world evidence programs.
Investigational continuous subcutaneous levodopa/carbidopa delivery
An investigational continuous subcutaneous delivery therapy for management of motor fluctuations in Parkinson’s disease evaluated in late-stage clinical trials.
Investigational melanocortin-receptor agonist program for porphyrias
An investigational small-molecule program targeting melanocortin receptors evaluated in late-stage clinical development for rare photosensitivity disorders.
Oral free-radical scavenger therapy for ALS (approved formulation)
An approved small-molecule antioxidant formulation indicated for treatment of amyotrophic lateral sclerosis; available in an oral formulation with associated post-approval safety monitoring and real-world evidence programs.
Investigational continuous subcutaneous levodopa/carbidopa delivery
An investigational continuous subcutaneous delivery therapy for management of motor fluctuations in Parkinson’s disease evaluated in late-stage clinical trials.
Investigational melanocortin-receptor agonist program for porphyrias
An investigational small-molecule program targeting melanocortin receptors evaluated in late-stage clinical development for rare photosensitivity disorders.
Services
Engagements with scientific communities to share clinical data, facilitate education, and support research collaborations.
Case management, benefits investigation, reimbursement and co-pay assistance, 24/7 clinical support, live nurse/clinical-educator contact, and virtual workflows to support patient access and treatment navigation.
Application-based support for educational programs, nonprofit sponsors and investigator-initiated research aligned to therapeutic focus areas.
Sponsorship and operational conduct of clinical studies including protocol execution, site enrollment, data collection, and regulatory reporting.
Partnerships and coordination with national home-infusion providers and alternate-site infusion centers to enable IV administration and broaden site-of-care options.
Collaborative initiatives with natural-history consortia and registries to collect longitudinal real-world datasets for observational research and evidence generation.
Engagements with scientific communities to share clinical data, facilitate education, and support research collaborations.
Case management, benefits investigation, reimbursement and co-pay assistance, 24/7 clinical support, live nurse/clinical-educator contact, and virtual workflows to support patient access and treatment navigation.
Application-based support for educational programs, nonprofit sponsors and investigator-initiated research aligned to therapeutic focus areas.
Sponsorship and operational conduct of clinical studies including protocol execution, site enrollment, data collection, and regulatory reporting.
Partnerships and coordination with national home-infusion providers and alternate-site infusion centers to enable IV administration and broaden site-of-care options.
Collaborative initiatives with natural-history consortia and registries to collect longitudinal real-world datasets for observational research and evidence generation.
Expertise Areas
- Neurodegenerative disease clinical development
- Phase 2/3 clinical trial management and site operations
- Biomarker study design and execution
- Real-world evidence generation and observational research
Key Technologies
- Clinical trial management systems
- Biomarker assay development
- Real-world data analytics
- Post-marketing safety surveillance systems